In this podcast, Ephraim L. Tsalik, MD, MHS, PhD, discusses the biomarkers in the pipeline for diagnosing infectious diseases, including tuberculosis and sepsis, and details which ones are most likely to make it to clinical practice.
Ephraim L. Tsalik, MD, MHS, PhD, is an associate professor of medicine, an associate professor in the Department of Molecular Genetics and Microbiology, and a member of the Duke Center for Applied Genomics and Precision Medicine at Duke University in Durham, North Carolina.
Additional Resources:
- Tsalik EL. The next generation of ID host response biomarkers. Talk presented at: IDWeek 2019; October 2-6, 2019; Washington, DC. https://cdmcd.co/gnXdk.
- Ross MH, Zick BL, Tsalik EL. Host-based diagnostics for acute respiratory infections [published online July 25, 2019]. Clin Ther. https://doi.org/10.1016/j.clinthera.2019.06.007.
- Lydon EC, Bullard C, Aydin M, et al. A host gene expression approach for identifying triggers of asthma exacerbations [published online April 8, 2019]. PLoS One. https://doi.org/10.1371/journal.pone.0214871.
- Duplessis C, Gregory M, Frey K, et al. Evaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis [published online November 13, 2018]. J Intensive Care. https://doi.org/10.1186/s40560-018-0341-5.
Disclosures:
BioFire: Grant/Research Support
Biomerieux: Grant/Research Support
CytoVale: Consultant
Immunexpress: Consultant
Predigen, Inc.: Officer or Board Member, Research Grant
Qvella: Other Financial or Material Support, Research Collaboration